A joint venture is detailing plans for a 3 million-square-foot, mixed-use campus in Jersey City that it says will be a hub for life sciences, technology and medicine just outside Manhattan.
Experts say New Jersey faces a growing challenge: While it’s still a major draw for pharmaceutical research and development, speed to market has become increasingly important to life sciences users. That means the state’s lack of move-in-ready lab space — and its lengthy approval process for new construction — puts it at a disadvantage to competing markets.
An Ohio-based company has added to its New Jersey holdings with its recent purchase of a 94-unit apartment building in Jersey City, in a deal arranged by Gebroe-Hammer Associates.
An attorney with Genova Burns LLC’s real estate and land use teams has earned a promotion to counsel, in one of several newly announced moves by the Newark-based law firm.
The buyer of an apartment and retail building in Jersey City has landed more than $17 million in financing, according to an advisory team with Progress Capital.
Land use consultancy Dresdner Robin has completed the first phase of environmental remediation at the site of what will be a mixed-use, two-tower development in Jersey City.
A joint venture has opened the doors to a new 145-unit apartment building on the west side of Jersey City, touting a design focused on local artists and cultural offerings.
Fisher Development Associates is set to open a second waterfront apartment tower in Jersey City, delivering another 452 homes to the growing Liberty Harbor neighborhood.